AVNS

AVNS

USD

Avanos Medical Inc. Common Stock

$12.290-0.170 (-1.364%)

Echtzeitkurs

Healthcare
Medizinprodukte
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$12.460

Hoch

$12.550

Tief

$12.150

Volumen

0.08M

Unternehmensfundamentaldaten

Marktkapitalisierung

565.4M

Branche

Medizinprodukte

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

0.49M

Börse

NYQ

Währung

USD

52-Wochen-Spanne

Tief $11.84Aktuell $12.290Hoch $25.36

KI-Analysebericht

Zuletzt aktualisiert: 1. Mai 2025
KI-generiertDatenquelle: Yahoo Finance, Bloomberg, SEC

AVNS: Avanos Medical Inc. Common Stock - What's Happening and What to Watch

Stock Symbol: AVNS Generate Date: 2025-05-01 10:35:32

Let's break down what's been going on with Avanos Medical stock and what the data might be hinting at. Think of this as getting the lowdown on the situation.

Recent News Buzz: Just the Facts

The main piece of news we have is pretty straightforward. Avanos Medical announced they'll be holding a webcast to talk about their financial results for the first quarter of 2025. This news came out a few days ago, on April 28th.

What does this mean? Well, it's standard procedure for a company. They're just letting investors know when and where they can hear the latest financial numbers and business updates directly from the company. It's not inherently good or bad news itself, but the content of that upcoming earnings call is definitely something to pay attention to. It's the next big event on the calendar for anyone following AVNS.

Price Check: A Look at the Chart

Now, let's look at what the stock price has actually been doing over the last few months. If you glance at the historical data, you'll see a pretty clear trend: it's been heading downwards. Back in early February, shares were trading up around the $16-$17 mark. Since then, there's been a noticeable slide.

The price dropped quite a bit through February and continued to drift lower through March and April. It recently hit its 52-week low, touching $11.84 in mid-April. Lately, in the last week or so of April, the price has been bouncing around a bit, mostly staying between $12.30 and $12.70. The last recorded price was $12.55.

So, the big picture on price is a significant decline, with the stock currently trading very close to its lowest point in a year.

What about the very near future? An AI model predicts the price might stay flat today (0.00% change), tick up slightly tomorrow (+0.67%), and then dip a tiny bit the day after (-0.25%). These are small predicted moves, suggesting things might be relatively stable right around this level in the immediate couple of days.

Putting It Together: Outlook & Ideas

Okay, so we have neutral news about an upcoming earnings call, a stock price that's been trending down sharply but is now hovering near its yearly low, and AI predictions for very small near-term price changes.

Based specifically on this mix, what does it suggest?

The significant price drop and the fact that it's near the 52-week low, combined with some technical indicators mentioned in the recommendation data (like the RSI suggesting it's "oversold" and a surge in trading volume on some recent down days which could indicate capitulation or buying interest at lows), might point to the possibility of a short-term bounce. The AI prediction of a slight positive move tomorrow also aligns a little with this idea.

However, we absolutely cannot ignore the overall downward trend and the fundamental concerns also highlighted in the recommendation data (like low growth, low return on equity, and high debt). These are serious points that explain why the stock has likely been falling.

So, the apparent near-term leaning, based on the "oversold" technical signals and the stock being at a yearly low, coupled with the AI's slight positive near-term prediction, seems to favor a potential short-term trading opportunity for those comfortable with risk. It doesn't scream "long-term buy" given the fundamental issues and the strong downtrend, but it might be on the radar for traders looking for a bounce from a low point.

Potential Entry Consideration: If someone were considering this stock based on the "oversold bounce" idea, the recommendation data suggests potential entry points around $12.73 or $12.81. These are right around the recent trading range. Entering near the current price ($12.55) or on any slight dip towards the recent low ($11.84) could also be considered, keeping in mind the 52-week low as a potential support area. The idea here is trying to catch a move up from a depressed level.

Potential Exit/Stop-Loss Consideration: Managing risk is key, especially with a stock in a downtrend. The recommendation data suggests a stop-loss at $11.44. This level is below the recent 52-week low, providing some buffer but cutting losses if the price continues to fall significantly. For taking profits, the data suggests $12.96. This is a relatively small target, fitting with the "short-term trading" horizon mentioned. It's just above the recent trading range, aiming for a quick gain if a bounce occurs.

Remember, these are just potential levels derived from the provided data and analysis. They are not guarantees.

Company Context: Who is Avanos Medical?

Just a quick reminder about the company itself: Avanos Medical is in the medical device business within the Healthcare sector. They make things like feeding tubes and pain management systems. They sell to hospitals and healthcare providers. It's a relatively small company with a market cap around $577 million. The fact that they are a smaller company can sometimes mean more volatility in the stock price. Also, their P/E ratio is quite low (around 7.5), which is why it might be flagged as potentially "undervalued" compared to some peers, even with the fundamental challenges.

Important Disclaimer

Please remember, this analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock investing involves significant risk, and you could lose money. Always do your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

Ähnliche Nachrichten

PR Newswire

Avanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2025 Financial Results

Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2025 on ...

Mehr anzeigen
Avanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2025 Financial Results

KI-VorhersageBeta

KI-Empfehlung

Bullisch

Aktualisiert am: 3. Mai 2025, 16:58

BärischNeutralBullisch

66.3% Konfidenz

Risiko & Handel

Risikostufe3/5
Mittleres Risiko
Geeignet für
Wert
Handelsleitfaden

Einstiegspunkt

$12.18

Gewinnmitnahme

$12.54

Stop-Loss

$11.06

Schlüsselfaktoren

PDI 9.3 liegt über MDI 5.1 mit ADX 20.8, was auf einen bullischen Trend hindeutet
Aktueller Preis ist extrem nah am Unterstützungsniveau ($12.21), was auf eine starke Kaufgelegenheit hindeutet
Handelsvolumen ist 11.3x Durchschnitt (5,040), was auf extrem starken Kaufdruck hindeutet
MACD -0.0001 liegt über der Signallinie -0.0123, was auf einen bullischen Crossover hindeutet

Bleiben Sie auf dem Laufenden

Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.